MPNST
Clinical trials for MPNST explained in plain language.
Never miss a new study
Get alerted when new MPNST trials appear
Sign up with your email to follow new studies for MPNST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple-Drug cocktail targets Hard-to-Treat sarcomas
Disease control Not yet recruitingThis study tests a combination of three drugs (selumetinib, ZEN-3694, and durvalumab) in people with advanced sarcomas, including a type called MPNST. The goal is to see if the combination is safe and can shrink tumors or stop them from growing. About 41 adults with sarcomas that…
Matched conditions: MPNST
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 26, 2026 07:54 UTC
-
New hope for rare nerve cancer: drug targets gene-mutated tumors
Disease control Not yet recruitingThis study tests a new medicine called BMS-986504 in people with a rare cancer called MPNST that has spread or cannot be removed by surgery. Only people whose tumors are missing a specific gene (MTAP) can join. The goal is to see if the drug can shrink tumors or slow the cancer's…
Matched conditions: MPNST
Phase: PHASE1, PHASE2 • Sponsor: Ankit Mangla, MD • Aim: Disease control
Last updated May 26, 2026 07:52 UTC